107 related articles for article (PubMed ID: 23598424)
1. FTIR spectral signature of anticancer drug effects on PC-3 cancer cells: is there any influence of the cell cycle?
Derenne A; Mignolet A; Goormaghtigh E
Analyst; 2013 Jul; 138(14):3998-4005. PubMed ID: 23598424
[TBL] [Abstract][Full Text] [Related]
2. The FTIR spectrum of prostate cancer cells allows the classification of anticancer drugs according to their mode of action.
Derenne A; Gasper R; Goormaghtigh E
Analyst; 2011 Mar; 136(6):1134-41. PubMed ID: 21249250
[TBL] [Abstract][Full Text] [Related]
3. Synchrotron FTIR analysis of drug treated ovarian A2780 cells: an ability to differentiate cell response to different drugs?
Flower KR; Khalifa I; Bassan P; Démoulin D; Jackson E; Lockyer NP; McGown AT; Miles P; Vaccari L; Gardner P
Analyst; 2011 Feb; 136(3):498-507. PubMed ID: 21088767
[TBL] [Abstract][Full Text] [Related]
4. Effects of the confluence rate on the FTIR spectrum of PC-3 prostate cancer cells in culture.
Gasper R; Goormaghtigh E
Analyst; 2010 Dec; 135(12):3048-51. PubMed ID: 20871930
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the hollow fiber assay for the determination of microtubule disruption in vivo.
Suggitt M; Swaine DJ; Pettit GR; Bibby MC
Clin Cancer Res; 2004 Oct; 10(19):6677-85. PubMed ID: 15475458
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic cancer cells retain the epithelial-related phenotype and modify mitotic spindle microtubules after the administration of ukrain in vitro.
Gagliano N; Volpari T; Clerici M; Pettinari L; Barajon I; Portinaro N; Colombo G; Milzani A; Dalle-Donne I; Martinelli C
Anticancer Drugs; 2012 Oct; 23(9):935-46. PubMed ID: 22700003
[TBL] [Abstract][Full Text] [Related]
7. Highlighting a need to distinguish cell cycle signatures from cellular responses to chemotherapeutics in SR-FTIR spectroscopy.
Hughes C; Brown MD; Ball FJ; Monjardez G; Clarke NW; Flower KR; Gardner P
Analyst; 2012 Dec; 137(24):5736-42. PubMed ID: 23095763
[TBL] [Abstract][Full Text] [Related]
8. FTIR spectral signature of the effect of cardiotonic steroids with antitumoral properties on a prostate cancer cell line.
Gasper R; Mijatovic T; Bénard A; Derenne A; Kiss R; Goormaghtigh E
Biochim Biophys Acta; 2010 Nov; 1802(11):1087-94. PubMed ID: 20656024
[TBL] [Abstract][Full Text] [Related]
9. Identification of benzo[a]pyrene-induced cell cycle-associated alterations in MCF-7 cells using infrared spectroscopy with computational analysis.
Pang W; Li J; Ahmadzai AA; Heppenstall LD; Llabjani V; Trevisan J; Qiu X; Martin FL
Toxicology; 2012 Aug; 298(1-3):24-9. PubMed ID: 22561278
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer and melanoma cell line identification by FTIR imaging after formalin-fixation and paraffin-embedding.
Verdonck M; Wald N; Janssis J; Yan P; Meyer C; Legat A; Speiser DE; Desmedt C; Larsimont D; Sotiriou C; Goormaghtigh E
Analyst; 2013 Jul; 138(14):4083-91. PubMed ID: 23689823
[TBL] [Abstract][Full Text] [Related]
11. Centrosome impairments and consequent cytokinesis defects are possible mechanisms of taxane drugs.
Zhu J; Beattie EC; Yang Y; Wang HJ; Seo JY; Yang LX
Anticancer Res; 2005; 25(3B):1919-25. PubMed ID: 16158926
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol interference with the cell cycle protects human neuroblastoma SH-SY5Y cell from paclitaxel-induced apoptosis.
Rigolio R; Miloso M; Nicolini G; Villa D; Scuteri A; Simone M; Tredici G
Neurochem Int; 2005 Feb; 46(3):205-11. PubMed ID: 15670636
[TBL] [Abstract][Full Text] [Related]
13. Comparison of 2-methoxyestradiol-induced, docetaxel-induced, and paclitaxel-induced apoptosis in hepatoma cells and its correlation with reactive oxygen species.
Lin HL; Liu TY; Chau GY; Lui WY; Chi CW
Cancer; 2000 Sep; 89(5):983-94. PubMed ID: 10964328
[TBL] [Abstract][Full Text] [Related]
14. Differential gene expression profiles in paclitaxel-induced cell cycle arrest and apoptosis in human breast cancer MCF-7 cells.
Wang J; He FT; Tzang CH; Fong WF; Xiao PG; Han R; Yang MS
Yao Xue Xue Bao; 2005 Dec; 40(12):1099-104. PubMed ID: 16496673
[TBL] [Abstract][Full Text] [Related]
15. Synergy of 5-aza-2'-deoxycytidine (DAC) and paclitaxel in both androgen-dependent and -independent prostate cancer cell lines.
Shang D; Liu Y; Liu Q; Zhang F; Feng L; Lv W; Tian Y
Cancer Lett; 2009 Jun; 278(1):82-7. PubMed ID: 19168279
[TBL] [Abstract][Full Text] [Related]
16. Measuring the complexity of cell cycle arrest and killing of drugs: kinetics of phase-specific effects induced by taxol.
Sena G; Onado C; Cappella P; Montalenti F; Ubezio P
Cytometry; 1999 Oct; 37(2):113-24. PubMed ID: 10486523
[TBL] [Abstract][Full Text] [Related]
17. Activation of the mitochondria-driven pathway of apoptosis in human PC-3 prostate cancer cells by a novel hydrophilic paclitaxel derivative, 7-xylosyl-10-deacetylpaclitaxel.
Jiang S; Zu Y; Fu Y; Zhang Y; Efferth T
Int J Oncol; 2008 Jul; 33(1):103-11. PubMed ID: 18575755
[TBL] [Abstract][Full Text] [Related]
18. Paclitaxel inhibits progression of mitotic cells to G1 phase by interference with spindle formation without affecting other microtubule functions during anaphase and telephase.
Long BH; Fairchild CR
Cancer Res; 1994 Aug; 54(16):4355-61. PubMed ID: 7913875
[TBL] [Abstract][Full Text] [Related]
19. Combined antimicrotubule activity of estramustine and taxol in human prostatic carcinoma cell lines.
Speicher LA; Barone L; Tew KD
Cancer Res; 1992 Aug; 52(16):4433-40. PubMed ID: 1353706
[TBL] [Abstract][Full Text] [Related]
20. Cell cycle-dependent antagonistic interactions between paclitaxel and gamma-radiation in combination therapy.
Sui M; Dziadyk JM; Zhu X; Fan W
Clin Cancer Res; 2004 Jul; 10(14):4848-57. PubMed ID: 15269161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
